Work

EPS3.05 GLPG2222 in subjects with cystic fibrosis homozygous for F508del: results from a phase II study (FLAMINGO)

Year: 2018

Type: article

Study design: Clinical Trial

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(18)30250-9

Authors: K.C. van der Ent, P. Minic, S. Verhulst, E. Van Braeckel, P. Flume, S. Boas, D. Geller, H. de Kock, S. Loyau, K. Muller, D. Kanters, K. Conrath, O. Van de Steen

Institutions: University Medical Center Utrecht, Sydney Children's Hospital, UNSW Sydney, Institut za zdravstvenu zaštitu majke i deteta Srbije "Dr Vukan Čupić", Antwerp University Hospital, Ghent University Hospital, McMaster University, Medical University of South Carolina, Great Ormond Street Hospital, Hospital for Sick Children, AbbVie (United States), Galapagos (Belgium), Galapagos (France)

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2807224488

FWCI: 0.541

Cites:

Cited by: 3

Related to: 10